The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A deep learning approach utilizing clinical and molecular data for identifying prognostic biomarkers in patients treated with immune checkpoint inhibitors: An ORIEN pan-cancer study.
 
Payman Ghasemi Saghand
No Relationships to Disclose
 
Issam El Naqa
Consulting or Advisory Role - Endectra
Patents, Royalties, Other Intellectual Property - Paten pending on new computing technology for decision making (Inst); Patent pending on an optical probe for radiation (Inst)
 
Aik Choon Tan
Research Funding - Bristol-Myers Squibb (Inst)
 
Mengyu Xie
No Relationships to Disclose
 
Donghai Dai
Employment - Immortagen
Leadership - Immortagen
Stock and Other Ownership Interests - Immortagen
Patents, Royalties, Other Intellectual Property - University of Iowa
 
James Lin Chen
Consulting or Advisory Role - Syapse; Tempus
Speakers' Bureau - Foundation Medicine
Research Funding - Eisai
Patents, Royalties, Other Intellectual Property - MatchTX
 
Aakrosh Ratan
Research Funding - AstraZeneca/MedImmune
 
Martin McCarter
Research Funding - Merck; Taiho Pharmaceutical
Other Relationship - Debbies Dream Foundation
 
John D. Carpten
Honoraria - Roche
Consulting or Advisory Role - Bristol Meyer Squibb; Roche/Genentech; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Methods related to Precision Medicine Know-How.; Royalty for IP (USC 2018-116) from drug licensed by Bridgene Biosciences, Inc.
Other Relationship - M2Gen
 
Harsh Shah
No Relationships to Disclose
 
Alexandra Ikeguchi
No Relationships to Disclose
 
Abhishek Tripathi
Honoraria - Urology times
Consulting or Advisory Role - Deka Biosciences; EMD Serono; Exelixis; Foundation Medicine; Genzyme; Pfizer; Seagen
Research Funding - Aravive (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); EMD Serono (Inst); Exact Sciences (Inst); Pfizer (Inst); WindMIL (Inst)
 
Igor Puzanov
Stock and Other Ownership Interests - Celldex; Celldex (I)
Consulting or Advisory Role - Amgen; Iovance Biotherapeutics; Merck; Nektar; Nouscom; Oncorus; Roche; Seneca Therapeutics
 
Susanne M. Arnold
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Exelixis (Inst); Genentech (Inst); Kura Oncology (Inst); LabCorp (Inst); Merck Sharp & Dohme (Inst); National Cancer Institute (Inst); Nektar (Inst); Ohio State University (Inst); Regeneron (Inst); Syneos Health (Inst)
 
Michelle L. Churchman
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - Dragonfly Therapeutics; Immatics
Consulting or Advisory Role - Dragonfly Therapeutics; Immatics
Research Funding - Genentech (Inst)
 
Jose Conejo-Garcia
Stock and Other Ownership Interests - Allogene Therapeutics; Anixa Biosciences; Compass Therapeutics
Honoraria - Allogene Therapeutics; Anixa Biosciences
Consulting or Advisory Role - Allogene Therapeutics; Anixa Biosciences; Compass Therapeutics
Research Funding - Anixa Biosciences
Patents, Royalties, Other Intellectual Property - Anixa Biosciences; Compass Therapeutics
 
William S. Dalton
Employment - M2GEN
Leadership - M2GEN
Stock and Other Ownership Interests - M2GEN
Consulting or Advisory Role - M2GEN
Research Funding - M2GEN
Patents, Royalties, Other Intellectual Property - Moffitt Cancer Center
Travel, Accommodations, Expenses - M2GEN
Other Relationship - M2GEN
 
George J. Weiner
Leadership - LIRECAP
Stock and Other Ownership Interests - LIRECAP
Consulting or Advisory Role - Regeneron
Research Funding - Checkmate Pharmaceuticals; Pfizer
 
Ahmad A. Tarhini
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Clinigen Group; Eisai; Genentech/Roche; Instil Bio; Merck; Novartis; Partner Therapeutics; Sanofi/Regeneron
Research Funding - Acrotech Biopharma (Inst); Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Genentech/Roche (Inst); InflaRx (Inst); Merck (Inst); OncoSec (Inst); Pfizer (Inst); Sanofi/Regeneron (Inst)